AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
May 2, 2014
30016_dirs_2014-05-02_817df80e-799c-468c-abdc-7f80289431d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-04-30
Reporting Person: MCKEON BRIAN P (Executive VP & CFO & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-30 | Common Stock | M | 4800 | $30.4950 | Acquired | 17141 | Direct |
| 2014-04-30 | Common Stock | S | 4800 | $126.05 | Disposed | 12341 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-30 | Non-Qualified Stock Option (right to buy) | $30.4950 | M | 4800 | Disposed | 2014-05-18 | Common Stock (4800) | Direct |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan (the "Plan") adopted by the reporting person on 02/20/2014. The Plan covers certain stock options held by the reporting person that will expire in 2014 and 2015 and will permit the sale of the shares received upon the exercise of such stock options and the payment of the applicable exercise prices and taxes due upon the exercise of such stock options.
F2: Grant of options to buy shares of common stock that vest one year from the date of grant (05/19/2005).